以糖尿病酮症酸中毒为表现的新型冠状病毒肺炎：病例系列
COVID-19 Presenting With Diabetic Ketoacidosis: A Case Series.
作者信息
Gorthi Ramya S, Kamel Ghassan, Dhindsa Sandeep, Nayak Ravi P
机构信息
Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, Missouri.
Division of Endocrinology, Diabetes and Metabolism, Saint Louis University School of Medicine, Saint Louis, Missouri.
出版信息
AACE Clin Case Rep. 2021 Jan-Feb;7(1):6-9. doi: 10.1016/j.aace.2020.11.010. Epub 2020 Dec 28.
Abstract
OBJECTIVE
Diabetes mellitus has been recognized as one of the comorbidities that predict the severity of illness in patients infected with COVID-19. The characteristics of patients presenting with diabetic ketoacidosis (DKA) and COVID-19 infection have not been described.
METHODS
We describe 5 patients with DKA and concomitant COVID-19 admitted to the intensive care unit of an academic medical center. Three patients had type 1 diabetes mellitus, and 2 patients had type 2 diabetes mellitus.
RESULTS
While DKA with an infectious etiology is a common presentation, we observed that the patients with DKA precipitated by COVID-19 presented with atypical symptoms. COVID-19 infection was revealed during search for an etiology of DKA.
CONCLUSION
It is prudent to have a low threshold to screen for COVID-19 infection in patients with DKA.
摘要
目的
糖尿病已被认为是预测新冠病毒病（COVID-19）感染患者疾病严重程度的合并症之一。目前尚未描述糖尿病酮症酸中毒（DKA）合并COVID-19感染患者的特征。
方法
我们描述了5例入住一所学术医疗中心重症监护病房的DKA合并COVID-19感染患者。3例为1型糖尿病患者，2例为2型糖尿病患者。
结果
虽然感染性病因导致的DKA很常见，但我们观察到由COVID-19引发DKA的患者表现出非典型症状。在寻找DKA病因的过程中发现了COVID-19感染。
结论
对DKA患者进行COVID-19感染筛查时保持较低的阈值是谨慎的做法。
相似文献
1
COVID-19 Presenting With Diabetic Ketoacidosis: A Case Series.以糖尿病酮症酸中毒为表现的新型冠状病毒肺炎：病例系列
AACE Clin Case Rep. 2021 Jan-Feb;7(1):6-9. doi: 10.1016/j.aace.2020.11.010. Epub 2020 Dec 28.
2
Diabetic Ketoacidosis and COVID-19: A Retrospective Observational Study.糖尿病酮症酸中毒与2019冠状病毒病：一项回顾性观察研究。
Cureus. 2022 Oct 31;14(10):e30895. doi: 10.7759/cureus.30895. eCollection 2022 Oct.
3
The Effect of the SARS-CoV-2 Pandemic on Presentation with Diabetic Ketoacidosis in Children with New Onset Type 1 Diabetes Mellitus.SARS-CoV-2 大流行对新发 1 型糖尿病儿童中以糖尿病酮症酸中毒就诊的影响。
J Clin Res Pediatr Endocrinol. 2023 Aug 23;15(3):264-267. doi: 10.4274/jcrpe.galenos.2023.2022-11-4. Epub 2023 Mar 29.
4
Diabetic ketoacidosis precipitated by COVID-19: A report of two cases and review of literature.由新型冠状病毒肺炎引发的糖尿病酮症酸中毒：两例报告及文献综述
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1459-1462. doi: 10.1016/j.dsx.2020.07.050. Epub 2020 Aug 1.
5
Euglycemic Diabetic Ketoacidosis With COVID-19 Infection in Patients With Type 2 Diabetes Taking SGLT2 Inhibitors.2型糖尿病患者服用SGLT2抑制剂时合并COVID-19感染出现正常血糖性糖尿病酮症酸中毒
AACE Clin Case Rep. 2021 Jan-Feb;7(1):10-13. doi: 10.1016/j.aace.2020.11.019. Epub 2020 Dec 28.
6
Diabetic ketoacidosis precipitated by atypical coronavirus disease in a newly diagnosed diabetic girl.一名新诊断糖尿病女孩中由非典型冠状病毒病诱发的糖尿病酮症酸中毒
J Taibah Univ Med Sci. 2021 Aug;16(4):628-631. doi: 10.1016/j.jtumed.2021.01.011. Epub 2021 Feb 16.
7
Euglycemic diabetic ketoacidosis in a patient with type 1 diabetes and SARS-CoV-2 pneumonia: case-report and review of the literature.1 型糖尿病合并 SARS-CoV-2 肺炎患者的血糖正常糖尿病酮症酸中毒：病例报告及文献复习。
Acta Clin Belg. 2022 Feb;77(1):113-117. doi: 10.1080/17843286.2020.1780390. Epub 2020 Jun 16.
8
SARS-CoV-2 Unmasks Type 1 Diabetes Mellitus With an Episode of Diabetic Ketoacidosis.严重急性呼吸综合征冠状病毒2型引发糖尿病酮症酸中毒发作，从而揭示出1型糖尿病。
J Med Cases. 2022 Sep;13(9):432-437. doi: 10.14740/jmc3963. Epub 2022 Sep 28.
9
A Case of Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus and COVID-19.1例2型糖尿病合并新型冠状病毒肺炎患者的正常血糖性糖尿病酮症酸中毒病例
Cureus. 2020 Dec 11;12(12):e12029. doi: 10.7759/cureus.12029.
10
Clinical characteristics and outcome in patients with combined diabetic ketoacidosis and hyperosmolar hyperglycemic state associated with COVID-19: A retrospective, hospital-based observational case series.与 COVID-19 相关的合并糖尿病酮症酸中毒和高渗高血糖状态患者的临床特征和结局：一项回顾性、基于医院的观察性病例系列研究。
Diabetes Res Clin Pract. 2020 Aug;166:108279. doi: 10.1016/j.diabres.2020.108279. Epub 2020 Jun 25.
引用本文的文献
1
Type 1 Diabetes and COVID-19: A Literature Review and Possible Management.1型糖尿病与2019冠状病毒病：文献综述及可能的管理方法
Int J Endocrinol Metab. 2023 Oct 23;21(4):e139768. doi: 10.5812/ijem-139768. eCollection 2023 Oct.
2
Risks associated with acute pancreatitis (AP) with diabetic ketoacidosis (DKA) in COVID-19 patients: a literature review.COVID-19患者中急性胰腺炎（AP）合并糖尿病酮症酸中毒（DKA）的相关风险：文献综述
J Diabetes Metab Disord. 2023 Apr 8;22(1):135-146. doi: 10.1007/s40200-023-01207-3. eCollection 2023 Jun.
3
Diabetic ketoacidosis, COVID-19 and blood viscosity.糖尿病酮症酸中毒、新型冠状病毒肺炎与血液黏稠度
J Taibah Univ Med Sci. 2022 Apr;17(2):343-344. doi: 10.1016/j.jtumed.2021.10.003. Epub 2021 Nov 11.
4
Diabetic ketoacidosis in patients with SARS-CoV-2: a systematic review and meta-analysis.2019冠状病毒病患者的糖尿病酮症酸中毒：系统评价与荟萃分析
Diabetol Metab Syndr. 2021 Oct 26;13(1):120. doi: 10.1186/s13098-021-00740-6.
5
The management of type 2 diabetes before, during and after Covid-19 infection: what is the evidence?新冠病毒感染前后 2 型糖尿病的管理：有哪些证据？
Cardiovasc Diabetol. 2021 Oct 1;20(1):198. doi: 10.1186/s12933-021-01389-1.
6
ACE2 function in the pancreatic islet: Implications for relationship between SARS-CoV-2 and diabetes.ACE2 在胰岛中的功能：SARS-CoV-2 与糖尿病之间关系的启示。
Acta Physiol (Oxf). 2021 Dec;233(4):e13733. doi: 10.1111/apha.13733. Epub 2021 Oct 2.
7
Post Covid-19 Infection Presenting as Rhino-Orbital Mycosis.新冠病毒感染后表现为鼻眶部真菌病
Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):3050-3057. doi: 10.1007/s12070-021-02722-6. Epub 2021 Jul 14.
本文引用的文献
1
Racial Disproportionality in Covid Clinical Trials.新冠临床试验中的种族不均衡现象。
N Engl J Med. 2020 Aug 27;383(9):e59. doi: 10.1056/NEJMp2021971. Epub 2020 Aug 11.
2
Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations.新型冠状病毒肺炎合并糖尿病酮症酸中毒：特殊关注点与注意事项
J Clin Endocrinol Metab. 2020 Aug 1;105(8). doi: 10.1210/clinem/dgaa360.
3
Prevalence of Gastrointestinal Symptoms and Fecal Viral Shedding in Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis.2019 年冠状病毒病患者的胃肠道症状和粪便病毒脱落的流行情况：系统评价和荟萃分析。
JAMA Netw Open. 2020 Jun 1;3(6):e2011335. doi: 10.1001/jamanetworkopen.2020.11335.
4
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.纽约市 5279 例 2019 年冠状病毒病患者住院和重症的相关因素：前瞻性队列研究。
BMJ. 2020 May 22;369:m1966. doi: 10.1136/bmj.m1966.
5
COVID-19 and Racial/Ethnic Disparities.新冠病毒病与种族/民族差异
JAMA. 2020 Jun 23;323(24):2466-2467. doi: 10.1001/jama.2020.8598.
6
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区，5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
7
COVID-19 and African Americans.新冠病毒与非裔美国人。
JAMA. 2020 May 19;323(19):1891-1892. doi: 10.1001/jama.2020.6548.
8
Diabetes is a risk factor for the progression and prognosis of COVID-19.糖尿病是新冠病毒疾病（COVID-19）进展和预后的一个风险因素。
Diabetes Metab Res Rev. 2020 Oct;36(7):e3319. doi: 10.1002/dmrr.3319. Epub 2020 Apr 7.
9
Commentary: COVID-19 in patients with diabetes.评论：糖尿病患者中的2019冠状病毒病
Metabolism. 2020 Jun;107:154217. doi: 10.1016/j.metabol.2020.154217. Epub 2020 Mar 24.
10
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.中国 COVID-19 患者 1590 例的合并症及其影响：一项全国性分析。
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00547-2020. Print 2020 May.
Zotero 插件